Regeneron high-dose Eylea gains FDA approval (NASDAQ:REGN)
Iryna Drozd The US FDA has approved Regeneron Pharmaceuticals' (NASDAQ:REGN) high-dose ("HD") version of its blockbuster therapy Eylea (aflibercept). The ...
Iryna Drozd The US FDA has approved Regeneron Pharmaceuticals' (NASDAQ:REGN) high-dose ("HD") version of its blockbuster therapy Eylea (aflibercept). The ...
© Reuters (Reuters) -The U.S. Food and Drug Administration (FDA) on Friday approved Biogen (NASDAQ:) and Sage Therapeutics' oral pill ...
© Reuters. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, ...
U.S. officials have approved the first over-the-counter birth control pill, which will let American women and girls buy contraceptive medication ...
© Reuters. FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in ...
Sena Yiğiter Intercept Pharmaceuticals (NASDAQ:ICPT) fell ~28% on Monday as its shares resumed trading after a group of independent experts ...
Women would receive a single injection late in pregnancy, between 24 weeks and 36 weeks, so they develop RSV-fighting antibodies ...
US regulators authorized a second round of omicron-targeted boosters for individuals older than 65 and those with weakened immune systems. ...
The fight over mifepristone comes less than a year after justices reversed Roe v. Wade and let several states effectively ...
For now, the drug remains available in wake of the separate rulings that were issued just minutes apart by federal ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.